These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. [Ultrafiltration in heart failure]. Antoniotti R; Antonucci E; Cremaschi E; Regolisti G; Cabassi A; Fiaccadori E G Ital Nefrol; 2012; 29(5):548-62. PubMed ID: 23117736 [TBL] [Abstract][Full Text] [Related]
83. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group. Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654 [TBL] [Abstract][Full Text] [Related]
84. Continuous Veno-Venous Hemofiltration Improves Survival of Patients With Congestive Heart Failure and Cardiorenal Syndrome Compared to Slow Continuous Ultrafiltration. Premuzic V; Basic-Jukic N; Jelakovic B; Kes P Ther Apher Dial; 2017 Jun; 21(3):279-286. PubMed ID: 28403554 [TBL] [Abstract][Full Text] [Related]
85. Worsening renal function in patients with acute decompensated heart failure treated with ultrafiltration: predictors and outcomes. Raichlin E; Haglund NA; Dumitru I; Lyden ER; Johnston MD; Mack JM; Windle JR; Lowes BD J Card Fail; 2013 Dec; 19(12):787-94. PubMed ID: 24216101 [TBL] [Abstract][Full Text] [Related]
87. Diagnosis characteristics and therapeutical options of infectious complications associated with peritoneal dialysis. Mihalache O; Doran H; Catrina E; Bobircă F; Mustatea P; Georgescu D; Pătrașcu T J Med Life; 2014; 7 Spec No. 3(Spec Iss 3):103-6. PubMed ID: 25870705 [TBL] [Abstract][Full Text] [Related]
88. Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Hanna MA; Tang WH; Teo BW; O'Neill JO; Weinstein DM; Lau SM; Van Lente F; Starling RC; Paganini EP; Taylor DO Congest Heart Fail; 2012; 18(1):54-63. PubMed ID: 22277179 [TBL] [Abstract][Full Text] [Related]
89. [Two case reports of refractory heart failure treated by continuous ambulatory peritoneal dialysis]. Okada M; Tanaka Y; Kasida M; Akatuka N; Suzuki Y; Yoshimoto K; Saima S; Nakamura Y; Tanaka T Kokyu To Junkan; 1993 Oct; 41(10):1013-8. PubMed ID: 8235116 [TBL] [Abstract][Full Text] [Related]
90. Peritoneal dialysis in patients with refractory congestive heart failure: potential prognostic factors. Kunin M; Arad M; Dinour D; Freimark D; Holtzman EJ Blood Purif; 2013; 35(4):285-94. PubMed ID: 23712042 [TBL] [Abstract][Full Text] [Related]
91. [Hemofiltration, ultrafiltration, and peritoneal dialysis for acute heart failure]. Morooka S Nihon Rinsho; 1992 Jan; 50 Suppl():278-83. PubMed ID: 1578692 [No Abstract] [Full Text] [Related]
92. Ultrafiltration in patients with decompensated heart failure and diuretic resistance: an Asian centre's experience. Teo LY; Lim CP; Neo CL; Teo LW; Ng SL; Chan LL; Kaushik M; Sim KL Singapore Med J; 2016 Jul; 57(7):378-83. PubMed ID: 26778634 [TBL] [Abstract][Full Text] [Related]
93. Ultrafiltration for management of fluid overload in patients with heart failure. Gologorsky RC; Roy S Artif Organs; 2020 Feb; 44(2):129-139. PubMed ID: 31361904 [TBL] [Abstract][Full Text] [Related]
94. Management of refractory ascites by using a peritoneal dialysis system with extracorporeal ultrafiltration by hemodialysis dialyzer. Itami N; Kimura J; Ohira S; Tsuji Y; Katsuki Y Perit Dial Int; 2003 Dec; 23 Suppl 2():S170-4. PubMed ID: 17986541 [TBL] [Abstract][Full Text] [Related]
95. Use of icodextrin during nocturnal automated peritoneal dialysis allows sustained ultrafiltration while reducing the peritoneal glucose load: a randomized crossover study. Rodríguez-Carmona A; Pérez Fontán M; García López E; García Falcón T; Díaz Cambre H Perit Dial Int; 2007; 27(3):260-6. PubMed ID: 17468473 [TBL] [Abstract][Full Text] [Related]
96. The impact of peritoneal dialysis upon quality of life and mortality of patients with end-stage congestive heart failure. Gotloib L; Fudin R Contrib Nephrol; 2006; 150():247-253. PubMed ID: 16721017 [TBL] [Abstract][Full Text] [Related]
97. Successful treatment with assisted automated peritoneal dialysis using 4.25% glucose dialysate for an elderly patient with refractory heart failure. Toda N; Iwaki R; Oishi K; Takasu Y; Komiya T CEN Case Rep; 2021 Feb; 10(1):121-125. PubMed ID: 32930999 [TBL] [Abstract][Full Text] [Related]
98. Icodextrin produces higher ultrafiltration in diabetic than in non-diabetic patients on continuous cyclic peritoneal dialysis. Ahmad M; Jeloka T; Pliakogiannis T; Tapiawala S; Zhong H; Bargman JM; Oreopoulos D Int Urol Nephrol; 2008; 40(1):219-23. PubMed ID: 17990071 [TBL] [Abstract][Full Text] [Related]
99. Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure. Agostoni PG; Guazzi M; Bussotti M; Grazi M; Palermo P; Marenzi G J Am Coll Cardiol; 2000 Nov; 36(5):1600-4. PubMed ID: 11079664 [TBL] [Abstract][Full Text] [Related]
100. Peritoneal Dialysis in Advanced Heart Failure Patients with Chronic Severe Congestion Resistant to Optimal Pharmacological Treatment. Murat S; Özkurt S; Çavuşoğlu Y Turk Kardiyol Dern Ars; 2022 Apr; 50(3):217-224. PubMed ID: 35450846 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]